Back to Search
Start Over
Supplementary Materials and Methods from Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary material and methods
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....b418cfd8466c7d5dc25c91df055d57f2
- Full Text :
- https://doi.org/10.1158/1535-7163.22505458.v1